Activity T1

Development of an imaging-based method for fibrosis localization and quantification in the heart with atrial fibrillation.

Activity T2

Development of superparamagnetic MRI contrast agents using a core/shell design, with enhanced biocompatibility and low toxicity.

Activity T3

Identification of possible causes of persistent atrial fibrillation using correlation analysis of the imaging-derived parameters with patient clinical data.

Activity T4

Performing functional MRI on the affected heart segments to identify functional effects of the structural changes.

Activity T5

Activities for the acquisition and protection of industrial property rights.